Medine.co.uk

Pioglitazone Hydrochloride 45mg Tablets

Informations for option: Pioglitazone Hydrochloride 45mg Tablets, show other option
Document: leaflet MAH GENERIC_PL 30139-0030 change

Package leaflet: Information for the user Pioglitazone Intas 15mg tablets Pioglitazone Intas 30mg tablets

Pioglitazone Intas 45mg tablets

Pioglitazone

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

•    Keep this leaflet. You may need to read it again.

•    If you have any further questions, ask your doctor or pharmacist.

•    This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

•    If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

What is in this leaflet

1.    What Pioglitazone Intas tablet is and what it is used for

2.    What you need to know before you take Pioglitazone Intas tablets

3.    How to take Pioglitazone Intas tablets

4.    Possible side effects

5.    How to store Pioglitazone Intas tablets

6.    Contents of the pack and other information


1. What Pioglitazone Intas tablet is and what it is used for

Pioglitazone Intas tablet contains pioglitazone. It is an anti-diabetic medicine used to treat type 2 (non-insulin dependent) diabetes mellitus when metformin is not suitable or has failed to work adequately. This is the diabetes that usually develops in adulthood.

Pioglitazone Intas tablets helps control the level of sugar in your blood when you have type 2 diabetes by helping your body make better use of the insulin it produces. Your doctor will check whether Pioglitazone Intas tablet is working 3 to 6 months after you start taking it.

Pioglitazone Intas tablets may be used on its own in patients who are unable to take metformin, and where treatment with diet and exercise has failed to control blood sugar or may be added to other therapies (such as metformin, sulfonylurea or insulin) which have failed to provide sufficient control in blood sugar.

2. What you need to know before you take Pioglitazone Intas tablets

Do not take Pioglitazone Intas tablets

•    if you are allergic to pioglitazone or any of the other ingredients of this medicine (listed in section 6).

•    if you have heart failure or have had heart failure in the past.

•    if you have liver disease

•    if you have had diabetic ketoacidosis (a complication of diabetes causing rapid weight loss, nausea or vomiting).

•    if you have or have ever had bladder cancer.

•    if you have blood in your urine that your doctor has not checked.

Warnings and precautions:

Talk to your doctor or pharmacist before taking Pioglitazone Intas tablets

•    if you retain water (fluid retention) or have heart failure problems in particular, if you are over 75 years old.

•    if you have a special type of diabetic eye disease called macular oedema (swelling of the back of the eye).

•    if you have cysts on your ovaries (polycystic ovary syndrome). There may be an increased possibility of becoming pregnant because you may ovulate again when you take Pioglitazone Intas tablets. If this applies to you, use appropriate contraception to avoid the possibility of an unplanned pregnancy.

•    if you have a problem with your liver or heart. Before you start taking Pioglitazone Intas tablets you will have a blood sample taken to check your liver function. This check may be repeated at intervals. Some patients with longstanding type 2 diabetes mellitus and heart disease or previous stroke who were treated with Pioglitazone Intas tablets and insulin experienced the development of heart failure. Inform your doctor as soon as possible if you experience signs of heart failure such as unusual shortness of breath or rapid increase in weight or localised swelling (oedema).

If you take Pioglitazone Intas tablets with other medicines for diabetes, it is more likely that your blood sugar could fall below the normal level (hypoglycaemia).

You may also experience a reduction in blood count (anaemia).

Broken bones

A higher number of bone fractures was seen in women (but not in men) taking pioglitazone. Your doctor will take this into account when treating your diabetes.

Children and adolescents

Use in children under 18 years is not recommended.

Other medicines and Pioglitazone Intas tablets

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

You can usually continue to take other medicines whilst you are being treated with Pioglitazone Intas tablets However, certain medicines are especially likely to affect the amount of sugar in your blood:

-gemfibrozil (used to lower cholesterol)

-rifampicin (used to treat tuberculosis and other infections)

Tell your doctor or pharmacist if you are taking any of these. Your blood sugar will be checked, and your dose of Pioglitazone Intas tablets may need to be changed.

Pioglitazone Intas tablets with food and drink:

You may take your tablets with or without food. You should swallow the tablets with a glass of water.

Pregnancy,breast-feeding and fertility:

Tell your doctor if

-    you are, you think you might be or are planning to become pregnant.

-    you are breast-feeding or if you are planning to breast-feed your baby.

Your doctor will advise you to discontinue this medicine.

Driving and using machines:

Pioglitazone will not affect your ability to drive or use machines but take care if you experience abnormal vision. Pioglitazone Intas tablets contains Lactose monohydrate:

This medicinal product contains lactose monohydrate. If you have been told by your doctor that you have intolerance to some sugars, contact your doctor before taking Pioglitazone Intas tablets.

3. How to take Pioglitazone Intas tablets_

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

The recommended dose is one tablet of 15/30/45 mg of pioglitazone should be taken once daily. If necessary your doctor may tell you to take a different dose.

If you have the impression that the effect of Pioglitazone Intas tablet is too weak, talk to your doctor.

When Pioglitazone Intas tablets are taken in combination with other medicines used to treat diabetes (such as insulin, chlorpropamide, glibenclamide, gliclazide, tolbutamide) your doctor will tell you whether you need to take a smaller dose of your medicines.

Your doctor will ask you to have blood tests periodically during treatment with Pioglitazone Intas tablets. This is to check that your liver is working normally.

If you are following a diabetic diet, you should continue with this while you are taking Pioglitazone Intas tablets.

Your weight should be checked at regular intervals; if your weight increases, inform your doctor.

If you take more Pioglitazone Intas tablets than you should

If you accidentally take too many tablets, or if someone else or a child takes your medicine, talk to a doctor or pharmacist immediately. Your blood sugar could fall below the normal level and can be increased by taking sugar. It is recommended that you carry some sugar lumps, sweets, biscuits or sugary fruit juice.

If you forget to take Pioglitazone Intas tablets

Take Pioglitazone Intas tablets daily as prescribed. However if you miss a dose, just carry on with the next dose as normal. Do not take a double dose to make up for a forgotten tablet.

If you stop taking Pioglitazone Intas tablets

Pioglitazone Intas tablets should be used every day to work properly. If you stop using Pioglitazone Intas tablets, your blood sugar may go up. Talk to your doctor before stopping this treatment.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects_

Like all medicines, this medicine can cause side effects, although not everybody gets them.

In particular, patients have experienced the following serious side effects:

Heart failure has been experienced commonly (may affect up to 1 in 10 people) in patients taking Pioglitazone Intas tablets in combination with insulin. Symptoms are unusual shortness of breath or rapid increase in weight or localised swelling (oedema). If you experience any of these, especially if you are over the age of 65, seek medical advice straight away.

Bladder cancer has been experienced uncommonly (may affect up to 1 in 100 people) in patients taking Pioglitazone Intas tablets. Signs and symptoms include blood in your urine, pain when urinating or a sudden need to urinate. If you experience any of these, talk to your doctor as soon as possible.

Localised swelling (oedema) has also been experienced very commonly in patients taking Pioglitazone Intas tablets in combination with insulin. If you experience this side effect, talk to your doctor as soon as possible.

Broken bones have been reported commonly (may affect up to 1 in 10 people) in women patients taking Pioglitazone Intas tablets. If you experience this side effect, talk to your doctor as soon as possible.

Blurred vision due to swelling (or fluid) at the back of the eye (frequency not known) has also been reported in patients taking Pioglitazone Intas tablets. If you experience this symptom for the first time, talk to your doctor as soon as possible. Also, if you already have blurred vision and the symptom gets worse, talk to your doctor as soon as possible.

The other side effects have been experienced by some patients taking Pioglitazone Intas tablets

common (may affect up to 1 in 10 people)

-    respiratory infection

-    abnormal vision

-    weight gain

-    numbness

uncommon (may affect up to 1 in 100 people)

-inflammation of the sinuses (sinusitis)

-difficulty sleeping (insomnia)

not known (frequency cannot be estimated from the available data)

-    increase in liver enzymes

The other side effects have been experienced by some patients when Pioglitazone Intas tablet is taken with other antidiabetic medicines are:

very common (may affect more than 1 in 10 people)

-    decreased blood sugar (hypoglycaemia)

common (may affect up to 1 in 10 people)

-    headache

-    dizziness

-    joint pain

-    impotence

-    back pain

-    shortness of breath.

-    small reduction in red blood cell count

-    flatulence

uncommon (may affect up to 1 in 100 people)

-    sugar in urine, proteins in urine

-    increase in enzymes

-    spinning sensation (vertigo)

-    sweating

-    tiredness

-    increased appetite

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

5. How to store Pioglitazone Intas tablets

•    Keep this medicine out of the sight and reach of children.

•    Do not use this medicine after the expiry date, which is stated on the blister and the carton after ‘EXP’. The expiry date refers to the last day of that month.

•    This medicinal product does not require any special storage conditions.

•    Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Pioglitazone Intas tablets contains

The active substance is pioglitazone.

Each tablet contains 15/30/45 mg of pioglitazone (as hydrochloride).

The other ingredients are:

Lactose monohydrate, Carmellose calcium, Hydroxypropyl cellulose (E 463), Magnesium stearate (E 572).

What Pioglitazone Intas tablets looks like and contents of the pack

15 mg: White to off white, round, biconvex, uncoated tablets debossed with ‘P’ on one side and ‘15’ on other side.

30 mg: White to off white, flat, round uncoated tablets with beveled edges debossed with ‘PIO’ on one side and ‘30’ on the other side.

45 mg: White to off white, flat, round uncoated tablets with beveled edges debossed with ‘PIO’ on one side and ‘45’ on the other side.

Pioglitazone Intas tablet is available in Aluminium/ Aluminium blister packs containing 14, 28, 30, 50, 56, 84, 90, 98, 112 and 196 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder:

Intas Pharmaceuticals Limited,

Sage house, 319, Pinner Road,

North Harrow, Middlesex HA1 4HF, UK

Manufacturer

Accord Healthcare Limited,

Sage house, 319, Pinner Road,

North Harrow, Middlesex HA1 4HF, UK

BIOTON S.A.

02-516 Warszawa, ul. Staroscinska 5 Poland

This leaflet was last revised in 04/2012.